Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer.

Edison XuElizabeth A DavidLi DingScott M AtayPaul M McFaddenSean C WightmanAnthony W Kim

Published in: Journal of surgical oncology (2020)

Neoadjuvant biologic therapy was associated with longer OS than adjuvant biologic therapy. Chemotherapy did not have an effect on OS when combined with biologic therapy and surgery.

Keyphrases

rheumatoid arthritis
minimally invasive
coronary artery bypass
locally advanced
rectal cancer
radiation therapy
surgical site infection
mesenchymal stem cells
coronary artery disease
atrial fibrillation
percutaneous coronary intervention
cell therapy
bone marrow